OpenVSafe by OpenVAERS
Search V-safe

99F-20503-51405

1 vaccination 4 coded responses 6 check-ins 4 free-text entries 0 call cases
Sex
Male
Age at first dose
12-15
ZIP prefix
222 / VA
Registered
2021-06-10
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-10
    Registered in v-safe
  2. 2021-06-10
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-10
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-06-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease, Type 1 diabetes mellitus — Feeling: Fair · Site: Pain
    Free text: (b)(6) had Type 1 Diabetes. His bgl ran high during the night and the first part of the day, and required extra insulin.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Diabetes mellitus, Pre-existing disease — Feeling: Fair · Site: Pain
    Free text: (b)(6)has diabetes. His bgl has run very high, with moderate ketones
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: (b)(6)has type 1 diabetes. His bgl continues to run high (although not quite as high as prior days), requiring additional insulin.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-06-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease — Feeling: Good
    Free text: No! (b)(6) has type 1 diabetes. The high bgls he was experiencing have completely subsided.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-06-10Pfizer-BioNTech

Free text

Release 9 — days 1–6 daily, dose 1

2021-06-11

Systemic reaction (other): (b)(6) had Type 1 Diabetes. His bgl ran high during the night and the first part of the day, and required extra insulin.
redacted (b)(6)

2021-06-12

Systemic reaction (other): (b)(6)has diabetes. His bgl has run very high, with moderate ketones
redacted (b)(6)

2021-06-13

Systemic reaction (other): (b)(6)has type 1 diabetes. His bgl continues to run high (although not quite as high as prior days), requiring additional insulin.
redacted (b)(6)

2021-06-15

Systemic reaction (other): No! (b)(6) has type 1 diabetes. The high bgls he was experiencing have completely subsided.
redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROBlood glucose increased ✓ ✓ ✓
SRODiabetes mellitus ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROType 1 diabetes mellitus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release